(Q46610203)

23 December 2017

title

Prophylactic antibiotics reduce morbidity due to septicemia during intensive treatment for pediatric acute myeloid leukemia (English)

1 reference

23 December 2017

0 references

0 references

1 reference

1 reference

7

Ching-Hon Pui

1 reference

23 December 2017

Beth Kurt

1

1 reference

23 December 2017

Patricia Flynn

2

1 reference

23 December 2017

Jerry L Shenep

3

1 reference

23 December 2017

Stanley Pounds

4

1 reference

23 December 2017

Shelly Lensing

5

1 reference

23 December 2017

Raul C Ribeiro

6

1 reference

23 December 2017

Bassem I Razzouk

8

1 reference

23 December 2017

Jeffrey E Rubnitz

9

1 reference

23 December 2017

language of work or name

English

0 references

publication date

1 July 2008

1 reference

23 December 2017

number of pages

7

1 reference

inferred from page(s)

published in

Cancer

1 reference

23 December 2017

volume

113

1 reference

23 December 2017

issue

2

1 reference

23 December 2017

page(s)

376-382

1 reference

23 December 2017

Meta-analysis: antibiotic prophylaxis reduces mortality in neutropenic patients

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23563

Treatment strategies and long-term results in paediatric patients treated in four consecutive AML-BFM trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23563

7 January 2021

Treatment strategy and long-term results in paediatric patients treated in consecutive UK AML trials

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23563

7 January 2021

Long-term results in children with AML: NOPHO-AML Study Group--report of three consecutive trials

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23563

7 January 2021

Early deaths and treatment-related mortality in children undergoing therapy for acute myeloid leukemia: analysis of the multicenter clinical trials AML-BFM 93 and AML-BFM 98.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23563

7 January 2021

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23563

7 January 2021

Death during induction therapy and first remission of acute leukemia in childhood: the St. Jude experience

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23563

7 January 2021

Viridans streptococci bacteremia in children with malignancy: relevance of species identification and penicillin susceptibility.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23563

7 January 2021

Alpha hemolytic streptococcal infection during intensive treatment for acute myeloid leukemia: a report from the Children's cancer group study CCG-2891

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23563

7 January 2021

Alpha-streptococcal septicemia in leukemic children treated with continuous or large dosage intermittent cytosine arabinoside

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23563

7 January 2021

Septicemia in pediatric oncology patients: the significance of viridans streptococcal infections

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23563

7 January 2021

Viridans streptococcal sepsis: clinical features and complications in childhood acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23563

7 January 2021

Microbiologically documented infections and infection-related mortality in children with acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23563

7 January 2021

Infectious complications in pediatric acute myeloid leukemia: analysis of the prospective multi-institutional clinical trial AML-BFM 93

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23563

7 January 2021

Attitudes of terminally ill cancer patients about euthanasia and assisted suicide: predominance of psychosocial determinants and beliefs over symptom distress and subsequent survival.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23563

7 January 2021

Clinical implications of FLT3 mutations in pediatric AML.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23563

7 January 2021

CDC definitions for nosocomial infections, 1988

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23563

7 January 2021

Low incidence of sepsis due to viridans streptococci in a ten-year retrospective study of pediatric acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23563

7 January 2021

Bacteremia due to viridans group Streptococci with diminished susceptibility to Levofloxacin among neutropenic patients receiving levofloxacin prophylaxis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23563

7 January 2021

Prophylactic levofloxacin to prevent infections in newly diagnosed symptomatic myeloma: the TEAMM RCT

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23563

7 January 2021

Antibacterial prophylaxis after chemotherapy for solid tumors and lymphomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23563

7 January 2021

Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23563

7 January 2021

Antibiotic prophylaxis in chemotherapy-induced neutropenia: time to reconsider

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23563

7 January 2021

Risk factors for new detection of vancomycin-resistant enterococci in acute-care hospitals that employ strict infection control procedures

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23563

7 January 2021

Identifiers

DOI

10.1002/CNCR.23563

1 reference

23 December 2017

1 reference

23 December 2017